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Available online 1 April 2016Background: It has been reported that contractility, as assessed using dobutamine infusion, is independently
associated with reverse remodeling after CRT. Controversy, however, exists about the capacity of this approach
to predict a long-term clinical response. This study's purposewas to assesswhether long-termCRT clinical effects
can be predicted according to acute inotropic response induced by biventricular stimulation (CRT on), as
compared with AAI–VVI right stimulation pacing mode (CRT off), quantiﬁed at the time of implantation.
Methods: In 98patients (ejection fraction 29±10%), acute changes in left ventricular (LV) elastance (Ees), arterial
elastance (Ea), and Ees/Ea, as assessed from slope changes of the force–frequency relation obtained when the
heart rate increased, and also assessed while measuring triplane LV volumes and continuous noninvasive
blood pressure, were related to death or rehospitalization during a 3-year follow-up. Other covariances tested
were age, gender, disease etiology, QRS duration, amount of mitral regurgitation, LV diastolic volume, ejection
fraction, and the degree of asynchrony and longitudinal strain at baseline.
Results: Therewas amarked increment in the Ees slopewith CRT (interaction P=0.004), no Ea change, andmod-
est Ees/Ea increase (interaction P b 0.05). In Cox analysis, however, neither slope changes nor baseline values of
Ees, Ea, and Ees/Ea were associated with long-term follow-up. Only ventricular diastolic volume (direct relation
P= 0.002) and QRS duration (inverse relation P= 0.009) predicted death/rehospitalization.
Conclusions: Acute contractile recovery in CRT patients is not associatedwith 3 years prognosis. Instead, death or
rehospitalization can be predicted from QRS duration and LV diastolic volume at baseline.
© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Congestive heart failure1. Introduction
Studies have reported that contractility, as assessed using dobuta-
mine infusion, is independently associated with reverse remodeling
after biventricular stimulation (CRT) [1–2]. Controversy, however, ex-
ists about the capacity of the inotropic challenge to predict a long-
term clinical response. A multicenter, prospective, observational study
of left ventricular (LV) contractile reserve, as assessed using low-dose
dobutamine infusion, was unable to demonstrate a signiﬁcantS, dyssynchrony; Ea, arterial
lastance; EF, ejection fraction;
tricle;MR,mitral regurgitation;
.
ion of the American College of
(P.N. Marino).
land Ltd. This is an open access articldifference in cardiac survival between patients who did or did not
achieve an absolute increase in LV ejection fraction N5 points during
the drug infusion [3]. Only the combination of cardiac survival and/or
heart failure hospitalization as a clinical end-point demonstrated a sig-
niﬁcant association with the inotropic challenge [3].
Increasing heart rates have long been recognized as a potentialmod-
ulator of systolic function [4]. In the normal heart, the force of contrac-
tions is augmented by an increase in heart rate, while in the failing
heart, alterations in the force–frequency relation (FFR) have been iden-
tiﬁed which potentially contribute to an impaired capacity for exercise
[5]. FFR has been shown to be capable of recruiting cardiac contractility
in the failing heart in excess of the CRT effect, with this positive FFR con-
tributing signiﬁcantly to the enhanced capacity for exercise that most of
the patients exhibit after the device implantation [6].
Thus, the purpose of this study was to assess whether and to what
extent the acute gain in contractility induced by CRT, as assessed during
increasing heart rate, is affecting long-term follow-up in terms of rehos-
pitalization or death of patients evaluated at the time of the device
activation.e under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Ninety-eight nonconsecutive patients (mean age 70.6 ± 8.3 years,
73 males) with congestive cardiomyopathy of nonischemic (n = 48)
or ischemic etiology (n= 50), LV ejection fraction (EF) b0.35 (0.30 ±
0.09), and QRS duration N120 ms (170 ± 28 ms), with left bundle
branch block morphology, except for 4 patients who exhibited a right
bundle branch blockwith left axis deviation,were prospectively studied
(Table 1). Ischemic cardiomyopathywas considered in the presence of a
documentedpreviousmyocardial infarction or a signiﬁcant coronary ar-
tery disease (luminal narrowing N70%) shown through coronary angi-
ography. Optimal revascularization had been previously performed in
those patients. Nonischemic cardiomyopathy was considered only in
the presence of angiographically “normal” coronary arteries. The pa-
tients, who fulﬁlled current criteria for CRT implantation, were selected
to be in spontaneous sinus rhythm, except for 8 patients who were per-
manently bradyarrhythmic because of atrial ﬁbrillation and 11 patients
with pacing-induced rhythm for various degrees of atrioventricular
block. In all these subjects a VVI pacemaker-induced regular rhythm
could be guaranteed during the entire procedure (see below).
Four patients had been previously implantedwith an aortic prosthe-
sis (2 mechanical and 2 biological valves) while 7 had received a
mechanical (n = 3) or a biological (n = 4) prosthesis in the mitral
position. Three patients had received a mitral plus an aortic mechanical
prosthesis, while 2 more patients had undergone mitral valve recon-
structive surgery. In all subjects written informed consentwas obtained
in accordance with institutional human review studies committee
guidelines and local institutional review board approval. The study
complies with the Declaration of Helsinki.
3. Echocardiographic measurements
Standard echocardiographic examinations were performed on all
patients using a Vivid 7 or Vivid E9 digital ultrasound system (GE
Medical Systems, Horten, Norway). Cardiac cycleswere stored in digital,
cineloop format for off-line analysis performed with a dedicatedTable 1
Basic demographics, etiology, therapy, and heart rhythm.
N 98
Age, years 71.2 ± 8.3
Gender (M/F), n 73/25
BSA, m2 1.84 ± 0.18
QRS width, ms 170 ± 30
Diabetes mellitus, % 30.4
NYHA functional class 2.7 ± 0.7
Device (ICD/PM), n 70/28
Etiology of heart disease, n
Idiopathic 31
Ischemic 43
Valvular 9
Ischemic/valvular 7
Others (post-hypertensive, postpartum,
tachicardiomyopathic, toxic)
8
Therapy, %
ACE inhibitors/ARB blockers 72
Amiodarone 33
Antialdosterone 20
Anticoagulants 24
Antiplatelets 64
Beta-blockers 76
Ca++ channel blockers 6
Digitalis 16
Diuretics 82
Nitrates 25
ECG rhythm, n
Spontaneous sinus rhythm 79
Permanent atrial ﬁbrillation 8
Advanced atrioventricular block 11software package (EchoPac PC, BT11 version; GE Healthcare). Two-
dimensional strain is a novel non-Doppler-based method to evaluate
strain from standard two-dimensional acquisitions [7]. By tracing
the endocardial contour on an end-systolic frame, the software will au-
tomatically track the contour on subsequent frames. Optimal tracking
could be veriﬁed in real-time and corrected by adjusting the region of
interest or manually correcting the contour. A minimum frame rate of
30 Hz was required for reliable operation of this software, and frame
rates of 30 to 80 Hz were used for routine gray-scale imaging.
Two-dimensional longitudinal strainswere assessed in 2 orthogonal
apical views (4- and 2-chambers, 12 segments) starting from the septal
and the inferior atrioventricular wall junction, respectively, and averag-
ing strains among various segments. The two-dimensional strain soft-
ware had to adequately track N80% of the attempted segments in
order to make the analysis acceptable.
Ventricular volumes were obtained using 3 real-time simultaneous
longitudinal planes, as imaged from the apical approach, and thenman-
ually tracing the endocardial border with built-in software. The papil-
lary muscles were excluded from the tracing. A triangular mesh was
constructed by 3D interpolation between the traces, and end-diastolic
volume and end-systolic volume were calculated by surface triangula-
tion and summation of all triangles by the divergence theorem [8].
Bland and Altman's analysis of LV volumes and EF has previously
demonstrated closer agreement between echocardiography and MRI
results using triplane imaging, as compared with biplane imaging,
both precontrast and with LV opaciﬁcation [9].
Evaluation of mitral regurgitation (MR) was graded quantitatively
according to the area of the regurgitant jet in a 4-chamber view using
the color Doppler data [10] and expressed as a ratio relative to the atrial
cavity area.
4. Asynchrony quantitation
Data for longitudinal strain curves were exported as digital ma-
trixes to a proprietary open-source analysis software (StrATo version
2.0.3.0). Dyssynchrony (DYS) was quantiﬁed by TUS (temporal uni-
formity of strain), where a time plot of regional strains, arranged
for ventricular location, was subjected to a Fourier analysis [11]. In
cases of a perfectly synchronous ventricle, the plot appeared as a
straight line, with power only in the 0-order Fourier term, whereas
regionally clustered DYS generated an undulating plot with higher
power in the 1-order term [12]. The TUS index, which reﬂects the
0-order relative to 1-order plus 0-order power, synthesized DYS mo-
tion data because this temporal variance index could distinguish be-
tween geographically clustered regions of shortening, which are out
of phase compared to those dispersed throughout the wall [13]. Due
to the large number of computations associated with dyssynchrony
calculation, one single beat was used for each view. Intraobserver re-
producibility for TUS measurements, as assessed in the longitudinal
plane in 15 patients at baseline heart rate (CRT off/on) and computed
as absolute mean difference± the percentage coefﬁcient of variation
(SD/mean), averaged 0.11 ± 1.0%, a value similar to what our group
previously reported [14].
5. Echocardiography protocol
Within 2–3 days after CRT implantation, patients underwent
echocardiographic-guided optimization (n = 77) or using the Quick-
Opt/Smart-Delay algorithm available with St. Jude/Boston Scientiﬁc de-
vices (n=21), respectively. Interventricular delaywas set ﬁxed at 0ms.
After optimization was obtained the device was programmed into one
of 2 basic modes: either AAI (right atrial pacing for patients with spon-
taneous rhythm) or VVI (right ventricular pacing for patients with per-
manent atrial ﬁbrillation or advanced atrioventricular block) pacing
mode vs. DDD-CRT (biventricular) pacingmode, in a random sequence.
In particular, during the AAI pacing mode, care was taken to conﬁrm
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6. Force–frequency relation (FFR) testing
Pacing was initiated at spontaneous heart rate, or at ﬁxed 70 beats/
min in those patients with permanent atrial ﬁbrillation or atrioventric-
ular block, with 2 subsequent steps at 100 and 120 beats/min lasting
for approximately 2 min. The other pacing mode was used to repeat
the same sequence after a fewminutes delay. During each step, contin-
uous blood pressure measurements (taken with the right arm) were
recorded using a digital photoplethysmography device capable of pro-
viding accurate beat-to-beat systolic and diastolic values (Finapress,
Omeda 2300, Monitoring Systems) [15]. Continuous blood pressure
signals were also visible on the screen of the echo machine (Fig. 1).
After the protocol was completed, the device was reprogrammed in
DDD-CRTmodewith a ﬁxed optimized AV and VV interval, with sched-
uled clinical follow-ups and device checks.
7. Effective arterial elastance and ventricular–vascular coupling
Arterial load and stiffness were indexed by the effective arterial
elastance (Ea), which is equal to the ratio of ventricular end-systolic
pressure (estimated as systolic blood pressure times 0.9) divided by
stroke volume, as assessed from the triplane volume [16]. Although Ea
does not directly reﬂect stiffness per se, it combines various aspects of
the total arterial input impedance into an effective stiffness, comprising
resistance, compliance, and characteristic impedance of the arterial
vascular bed [17]. Ventricular contractility (Ees) was indexed by the
end-systolic pressure–volume ratio, neglecting the volume intercept
of the end-systolic pressure–volume relationship [18]. Ventricular–
vascular coupling was indexed by the Ees/Ea ratio.
8. Statistical analysis
Data are expressed as mean ± 1 SD (unless otherwise stated), with
the Kolmogorov–Smirnov test used to assess normality of data.Fig. 1.Methodology adopted for the study. Ventricular volumes were obtained using real-time
border with in-built software. Calibrated continuous blood pressure, together with ECG signal,Differences between means were assessed using paired and unpaired
t-tests as appropriate. A signed-rank test was used if data were not nor-
mally distributed.
A two-way repeated-measures analysis of variance was used to as-
sess the effects of progressively increasing the heart rate over time on
changes in ventricular volumes, Ees, Ea, and their ratio (Ees/Ea) in the
overall population, with the effect of pacing mode (DDD-CRT vs. AAI–
VVI) as a between-patient factor. The Holm–Sidak test was used for
multiple pairwise comparisons. Furthermore, in each patient regression
analysis (least-squares method) was used to assess the slope of the FFR
relation obtained plotting Ees, Ea, and their ratio (dependent variables)
against increasing heart rate (independent variable) during DDD-CRT
vs. AAI–VVI pacing mode.
A best subsets regression model was then developed in order to
identify which subset of baseline clinical or echocardiographic vari-
ables (slope of Ees, Ea, and Ees/Ea ratio obtained in AAI–VVI pacing
mode and its signiﬁcant CRT-induced acute change, along with age,
QRS duration, amount of mitral regurgitation, LV diastolic volume,
ejection fraction, TUS, and longitudinal strain at baseline) best con-
tributed to predicting heart failure and rehospitalization or death.
The adjusted r squared value (r2) was used to measure how well
the selected set described the dependent variable, taking into ac-
count the number of independent variables. Then, a Cox stepwise re-
gression model was developed in order to identify which of those
selected variables, beside gender and etiology of cardiac disease (is-
chemic vs. nonischemic), predicted heart failure, rehospitalization,
or death (whichever came ﬁrst) during a 3-year follow-up period.
Results of the Cox proportional hazards model are presented as haz-
ard ratio (HR) [95% CI].
We reasoned that 98 patients would allow us to detect a
0.0053 mm Hg/ml/m2/beats/min Ees slope change (CRT off/on) during
heart rate increments among those subjects that experienced rehospi-
talization due to heart failure, or death, over a 3-year follow-up period,
compared to those who did not, with a power = 0.80 and α= 0.05,
assuming a Ees slope SD equal to 0.013 mm Hg/ml/m2/beats/min.
Finally, a Kaplan–Meier survival analysis was performed using log-
rank statistics and a post hoc Holm–Sidak test. A P value b 0.05 was3 apical simultaneous longitudinal planes and then by manually tracing the endocardial
was also available on the screen of the echo machine.
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SigmaPlot (version 12.5 for Windows, Jandel; San Rafael, CA) statistical
software.
9. Results
Ventricular cavities at baseline (measured during AAI–VVI pacing
mode) were markedly dilated (90.1 ± 27.1 ml/m2 for diastolic,
64.7±23.8ml/m2 for systolic volumes) and pump functionwas severe-
ly depressed (EF 0.29 ± 0.10). Longitudinal strain was also depressed
(−7.6 ± 3.5%), as reported in comparable populations [19].
9.1. Effects of FFR
No patient complained of angina during the pacing protocol, and in
all patients data were re-evaluated after CRT was activated. Fig. 2 illus-
trates assessment of FFR during different modes of stimulation, for
ventricular volumes, Ea, and Ees.
There were no differences in diastolic volumes between DDD-CRT
vs. AAI–VVI pacing modes during FFR, with volumes declining signiﬁ-
cantly with heart rate increments (P b 0.001 for trend, Fig. 2A). Such
ventricular volumetric decrement during FFR was also true for stroke
volumes (P b 0.001 for trend), butwith a signiﬁcant interaction between
time-changes in ejected blood during DDD-CRT pacing mode (−10 ±
44%) as compared with AAI–VVI pacing mode (−12 ± 45%, P= 0.027
for interaction) (Fig. 2B). A relatively smaller reduction in stroke volume
with DDD-CRT pacing mode developed, with no difference in Ea
between the 2 pacing modes (NS for interaction), although overall Ea
increased progressively with increasing heart rates (P b 0.001 for
trend, Fig. 2C).Fig. 2. Assessment of FFR during different modes of stimulation, as far as diastolic and ventric
between AAI/VVI (CRT off) vs. biventricular pacing mode (CRT on) during FFR, although ca
volumetric decrement during FFR was true for stroke volumes too (P b 0.001 for trend), but
(−10 ± 44%) compared to AAI–VVI pacing mode (−12 ± .45%, P = 0.027 for interaction)
difference in Ea between the 2 pacing modes (NS for interaction), although overall Ea increa
challenge was concerned, Ees increased signiﬁcantly during heart rate increments in DDD-CRT
data are displayed as absolute changes, normalized to the index (CRT off) baseline value.As far as inotropic challenge was concerned, Ees increased signiﬁ-
cantly during heart rate increments in DDD-CRT pacing mode, whereas
it decreased in AAI–VVI pacing mode (Fig. 2D, interaction P b 0.001).
This caused a modest improvement in the Ees/Ea ratio during DDD-
CRT pacing mode (P= 0.03 for interaction), although the ratio overall
decreased signiﬁcantly during FFR testing (P b 0.001 for trend [data
not shown]).
9.2. Assessment of discoordination and pacing mode
Effects of CRT vs. AAI–VVI pacing modes, as assessed at baseline,
demonstrated a signiﬁcant improvement in ventricular discoordination
(TUS from 0.56 ± 0.16 to 0.61 ± 0.14, P b 0.03), albeit not mirrored by
any signiﬁcant change in longitudinal strain generation (from−7.6 ±
3.5% to−7.7 ± 3.1%, P= 0.31). There was also a borderline reduction
in the amount of mitral regurgitation with CRT on (jet area/atrial area
from 0.11 ± 0.11 to 0.09 ± 0.10, P = 0.067), compared to with AAI–
VVI pacing mode, as computed at baseline.
9.3. Clinical outcomes
Follow-up data (mean duration 849 ± 443 days), obtained from
hospital records and/or telephone interviews with patients or their
relatives, were available for all subjects. A total of 24 patients reached
the end-point (8 deaths, 16 patients with rehospitalization due to
heart failure).
According to paired testing only the acute change in the Ees slope
(from−0.003 ± 0.013 to +0.002 ± 0.013 mm Hg/ml/m2/beats/min,
P=0.004), taken as a cumulative descriptor of the inotropic ventricular
response to CRT, was included in the multivariate analysis, besides the
other analysis already indicated covariates. Changes in the Ea and inular ﬁlling volumes, Ees, and Ea are concerned. There is no difference in diastolic volume
vity declines signiﬁcantly with heart rate increments (P b 0.001, A). Such ventricular
with a signiﬁcant interaction between time-changes in ejected blood during DDD-CRT
(B). This relative smaller reduction in stroke volume with DDD-CRT developed with no
sed progressively with increasing heart rates (P b 0.001 for trend, C). As far as inotropic
, whereas it decreased in AAI–VVI pacing mode (D, interaction P b 0.001). For Ea and Ees,
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further.
Three variables (diastolic ventricular volume, QRS duration, and
acute change in Ees slope) were ﬁnally identiﬁed (best adjusted r2
0.082) and used, with gender and etiology of cardiac disease (ischemic
vs. nonischemic), in the Cox regression analysis. The Coxmodel showed
that only diastolic ventricular volume (HR 1.03 [95% CI 1.01–1.04], P=
0.001) and QRS duration (HR 0.98 [95% CI 0.96–1.00], P = 0.019)
at baseline, duringAAI–VVI pacingmode, predicted heart failure exacer-
bations, requiring hospitalization or leading to death, at follow-up. No
prognostically signiﬁcant contribution could be obtained from the
other covariates included in the model.
In order to conﬁrm that greater cardiac remodeling at baseline and
shorter QRS duration affected survival after CRT, we performed a
Kaplan–Meier analysis classifying the CRT population based on the
median end-diastolic volume (EDV) (87 ml/m2) and QRS duration
(164ms) for the entire population. Thus, 3 groups were created accord-
ing to the values of EDV and QRS compared to the related medians
(Group 1, n = 27: EDV b 87 ml/m2 and QRS ≥ 160 ms; Group 2, n =
51: EDV N 87 ml/m2 and QRS ≥ 160 ms or EDV b 87 ml/m2 and
QRS b 160 ms; Group 3, n= 20: EDV N 87 ml/m2 and QRS b 160 ms).
Event-free survival curves for the 3 groups, shown in Fig. 3, were
signiﬁcantly different (log-rank test P = 0.012). Group 3 event-free
survival was less than 1/3 than that of Group 1 at the end of follow-
up. Furthermore, Group 3 event-free survival rapidly decreased in the
ﬁrst 1000 days after CRT. In contrast, Group 1 event-free survival stayed
around 90% until the end of the observation period. The difference,
based on a post hoc Holm–Sidak test, was statistically signiﬁcant (P=
0.015). Group 2 exhibited an intermediate trend, with improved
event-free survival compared to Group 3, but worse than that of
Group 1, although not at a signiﬁcant level (Fig. 3).
Results could not be explained bydifferences in the drugdistribution
among the 3 groups. The percentages of patients treated with beta-
blockers (78%, 82%, 75%), diuretics (85%, 84%, 90%), and ACE inhibi-
tors/AT1 antagonists (85%, 71%, 70%)were not dissimilar among groups.Fig. 3. Survival curveswere obtained bydividing patients into 3 groups according to values of ve
groupswere thus created: Group1, n=27: EDV b 87ml/m2 andQRS ≥ 160ms; Group2, n=51
EDV N 87ml/m2 and QRS b 160ms. Event-free survival curveswere signiﬁcantly different amon
of the rate of Group 1 at the end of follow-up, and rapidly decreased in theﬁrst 1000days after C
observation period. The difference, based on a post hoc Holm–Sidak test was statistically sign
survival as compared with Group 3, but worse relative to Group 1, although not at a signiﬁcan9.4. Variability of analysis
Interobserver reproducibility of Ees slopes with CRT on/off was de-
termined by the blind operator 12months apart for 13 randomly select-
ed patients. The correlation coefﬁcient for the Ees slopes between the 2
measurements was 0.62 (P b 0.001) (Fig. 4, left). A plot of the average
between the repeated Ees slope measurements against their difference
demonstrated no over- or underestimation, but the dispersion of the
data was slightly larger for CRT off compared to CRT on (Fig. 4, right).
10. Discussion
Our study conﬁrmed that in patientswith advancedheart failure and
intraventricular conduction abnormalities, the correction of baseline
asynchronywith CRT activation resulted in an acute increase in contrac-
tility, which mediated some improvement in ventricular–vascular cou-
pling. The acute increment in the FFR steepness with CRT, however, was
unable to predict rehospitalization due to heart failure, or death, during
a 3-year follow-up. Rather, QRS duration (direct relation) and ventricu-
lar diastolic volume (inverse relation), as assessed at the time of device
implantation, did stratify patients long-term.
10.1. Correction of asynchrony and acute recruitment of contractility
In our study, we provided further evidence that asynchrony
correction with CRT improved contractility in heart failure patients.
This same effect was shown by Vollmann et al., who demonstrated
that biventricular pacing improved the blunted force–frequency rela-
tion that was present in 22 subjects with heart failure and ventricular
conduction delay [6]. In their study, progressive increases in positive
dP/dtmax were demonstrated with increasing heart rate with CRT on,
without major changes in preload [6].
It was not clear why the FFR was steeper with CRT. Our data sug-
gested that different pacing modes affected asynchrony, which led to
disparities in the FFR response, previously reported as unexplainablentricular diastolic volume (EDV) andQRS duration compared to the relatedmedians. Three
: EDV N 87ml/m2 andQRS ≥ 160ms or EDV b 87ml/m2 andQRS b 160ms; Group 3, n=20:
g the 3 groups (log-rank test P=0.012). Group 3 event-free survival rate was less than 1/3
RT. In contrast, Group 1 event-free survivalwasmaintained around 90%until the end of the
iﬁcant (P= 0.015). Group 2 exhibited an intermediate trend, with improved event-free
t level. EDV = end-diastolic volume.
Fig. 4. Plot of regression between 2 Ees slope measurements performed 12 months apart by a different reader (left). There is a signiﬁcant correlation between the 2 measurements (r=
0.62, P b 0.001). Also, a plot of the average of the 2 measurements against their difference showed good agreement (right), but the dispersion of the data was slightly larger for CRT off as
compared with CRT on.
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the state of various related proteins [20]. The same beneﬁcial effect
from CRT should be anticipated for the LV diastolic properties, given
that acute increases in heart rate accelerate early relaxation in patients
with heart failure [21]. Using speckle-tracking echocardiography we
conﬁrmed that asynchrony modulation, as assessed longitudinally,
was associated with a positive inotropic response in CRT pacing mode
that favored, only a modest improvement in ventricular–vascular cou-
pling [22,23].
10.2. Prediction of long-term clinical outcome according to acute
recruitment of contractility
Many papers have been published on the use of an inotropic chal-
lenge in order to predict prognosis in CRT patients. Most of these papers
have focused on the short-term anti-remodeling effect of CRT. Ypenburg
et al. [1] showed that myocardial contractile reserve (deﬁned as N7.5%
points increment in ejection fraction during low-dose dobutamine infu-
sion) predicted, with a 76% sensitivity and a 86% speciﬁcity, reverse re-
modeling 6 months after CRT in 31 consecutive heart failure patients.
Similarly, Tucillio et al. [2] demonstrated in 42 CRT patients that a 25%
relative increment in ejection fraction during a dobutamine stress-
echo test was a strong predictive factor 6 months after CRT (cut-off for
CRT response was an LV end-systolic volume reduction of 15%).
Other papers have examined survival and/or re-hospitalization due
to heart failure for long-term periods [3,24]. While the different studies
on the short-term anti-remodeling effect are relatively concordant,
this is not true for long-term clinical effects. In the only available
randomized study on this topic, conducted in 221 CRT patients, it
was clear that the end-point was reached only when the 5% point
increment in ejection fraction induced by low-dose dobutamine infu-
sion (5–20 μg/kg/min) was contrasted against the combined ﬁndings
of death and re-hospitalizations due to heart failure that were docu-
mented during the 15-month follow-up [3]. No difference was detected
using mortality alone.
The results of our analysis were uncertain because we could not
use results of acute improvement in contractility with CRT to stratify
patients long-term. It is possible that the FFR-induced increment in
inotropy in our study (+3 ± 0.9% points absolute increment in ejec-
tion fraction between CRT vs. AAI–VVI pacing modes at maximum
heart rate achieved [data not shown]), which was less than what
we obtain with dobutamine infusion (N5 points absolute increment
in the LODO-CRT trial [3]), was inadequate for evoking any obviousbeneﬁcial effect during the follow-up. In any case, it remains unclear
whether a response to early surrogate testing would identify the
chronic responders to CRT with respect to hard clinical end points
[25]. This reasoning is in line with another report that described
how the acute improvement in dP/dtmax was not correlated to the
clinical outcome, although dP/dtmax, measured at baseline and dur-
ing CRT, was a predictor of 1-year survival free from mortality,
heart transplantation, or LV assist device implantation [26]. Thus, it
might be that the acute response in contractility, in our study as
well as in other studies, might have been a measure of response to
CRT than an indicator of prognosis per se.10.3. Ventricular elastance (Ees) and long-term prognosis in heart failure
patients
It must be stressed that the Ees slope change with CRT in our study
was highly signiﬁcant (Fig. 2B), almost double its baseline value,
although we could not use it to stratify patients long-term. In a very re-
cent study another group demonstrated comparable results. In a large
population of 446 chronic heart failure participants in the Penn Heart
Failure Study, with a reasonable proportion (24%) of CRT-implanted
subjects, Ky et al. [27] showed that noninvasive Ees was unable to
exert prognostic stratiﬁcation (combined endpoint of death, cardiac
transplantation, or ventricular assist device placement and cardiac hos-
pitalization) over a 6-year follow-up, in either unadjusted or adjusted
models. Unlike that study, however, in our study we could not stratify
patients long-term based on ventricular elastance, arterial elastance,
or their ratio. These ﬁndings were unexpected given that the same
Penn Heart Failure Study group demonstrated that Ea and
ventricular–arterial coupling were able to exert long-term prognostic
stratiﬁcation [27].
We haveno clear-cut explanation for these discrepancies apart, from
the values of Ea beingmuch higher in our study compared to Ky's study
[27]. This difference is the consequence of the lower values of systolic LV
pressures (median, 25th and 75th percentiles: 109 [96–124] mmHg vs.
120 [102–140]mmHg) and larger stroke volumes (59 [45–76]ml vs. 45
[35–57] ml) generated in their study population compared to our study
population. These differences, along with their prognostic implications,
underline potential margins of therapeutic improvement in our cohort,
while reinforcing the importance of an aggressive afterloading therapy
in subjects with depressed pump performance. They also attenuate
the pathophysiological “weight” of LV chamber elastance alone,
72 F. DeVecchi et al. / IJC Heart & Vasculature 11 (2016) 66–73compared to the arterial properties and the ventricular–vascular cou-
pling, in the long-term prognosis of such patients [27,28].
10.4. QRS duration and degree of adverse remodeling pre-CRT as predictors
of long-term clinical outcome
In our study ventricular diastolic volume (direct relation P=0.001)
and QRS duration (inverse relation P=0.019), as measured at baseline,
predicted death or rehospitalization long term. These ﬁndings conﬁrm
previous reports that have shown that the degree of LV adverse remod-
eling [29] and baseline QRS duration [29,30], alone or in combination,
predicted CRT response.
Sipahi et al. [30] conducted a meta-analysis of 5813 patients and
found that there was a signiﬁcant relationship between baseline QRS
duration and risk ratio, with a beneﬁt of CRT in patients with severely
prolonged QRS intervals. Also Park et al. [29] showed in 100 patients
that QRS durations, along with LV end-diastolic volume, predicted CRT
response (deﬁned as a decrease in LV end-systolic volume of ≥15%
and/or an absolute increase of 5% in ejection fraction) at 6-months
follow-up.
These studies, however, contrastwith otherswhich suggest that QRS
duration is not predictive of clinical and echocardiographic responses
during short-term follow-up [30–32]. For example Mollema et al. [32]
found that QRS duration in 242 subjects was not predictive for clinical
(improvement of ≥1 grade in New York Heart Association class) and
echocardiographic (decrease N10% in LV end-systolic volume) re-
sponses to CRT 6 months after implantation. Similarly, Molhoek et al.
[33] showed that QRS duration at baseline is not predictive for clinical
response to CRT (improvement of NYHA class, 6-minute walking dis-
tance and quality of life score) in 61 patients over 6 months follow-up.
They demonstrated that responders exhibit a shortening QRS duration
only after CRT, but individual response varied highly.
A direct relationship exists between increased QRS duration and
advanced LV dilatation in patients with ischemic cardiomyopathy, a
large amount of nonviable muscle in the posterolateral wall, and poor
LV function [34]. In our study, where no signiﬁcant differences could
be found in terms of QRS duration or baseline LV remodeling between
ischemic vs. nonischemic patients, the combination of longer QRS dura-
tion and smaller end-diastolic volume at baseline imposed better
survival rates, based on the composite clinical endpoint of worsening
heart failure and cardiac death (Fig. 3). Also in the large population of
446 participants in the Penn Heart Failure Study a clear negative prog-
nostic impact of LV end-diastolic volume and risk of cardiac hospitaliza-
tionwas evident [27], reﬂecting the tight relationship between chamber
remodeling and the degree of contractile dysfunction.
11. Limitations
Some limitations in our work need to be considered. DYS could not
be assessed during the entire FFR protocol, and thus potential deviations
from what we have described during baseline AAI/VVI vs. CRT pacing
modes could not be assessed. This limitation in the study design could
also explain discrepancies between our study results and our previous
publications [11,12] and other groups' studies [13]. It is likely that new
3D speckle tracking echocardiography will represent a more robust
method for reconciling quantiﬁcation of intraventricular mechanical
dyssynchrony during CRT therapy along the various axes [35].
Ventricular elastance was not estimated using the single-beat algo-
rithm proposed by Chen et al. [36], due to the difﬁculty in obtaining
timing landmarks during the acquisition protocol, which prevented us
from computing the intercept (V0), beside the slope (Ees), of the end-
systolic pressure–volume relationship. We acknowledge this limitation
but considering theﬁndings of the PennHeart Failure Study,which used
single-beat LV systolic elastance [27], we are conﬁdent that the use of a
more sophisticated approach to assess cardiac contractility would not
have substantially modiﬁed our ﬁnal conclusions.Invasively assessed stroke work (SW) has been reported as a sensi-
tive predictor of long-term CRT response in a 41-patient study [37], in
which responders (n = 29) exhibited an acute increase in SW with
CRT activation signiﬁcantly higher (+57 ± 33% vs. +10 ± 30%, P =
0.001) compared to nonresponders (n = 12). Furthermore, the acute
inotropic recruitment did stratify long-term,whereas the acute increase
in dP/dtmax did not, showing no difference between the 2 groups
(+15 ± 18% vs. +6 ± 15%, NS) [37]. In our study, computation of SW
slope (derived as mean arterial blood pressure multiplied by stroke
volume) against heart rate increments with CRT (on/off) demonstrated
a signiﬁcant interaction (P= 0.01), with CRT on exhibiting higher SW
compared to CRT off (Appendix). However, substitution of Ees with
SW in the Cox analysis did not change our ﬁnal conclusion. Differences
in the follow-up duration and end-points (death and/or rehospitaliza-
tion due to heart failure within 3 years vs. reverse remodeling N15%
within 1 year) could in part explain the discrepancy.
12. Conclusion
Correction of DYS is associated with acute contractile recovery in
heart failure patients during CRT pacing mode vs. AAI/VVI pacing
mode. Acute contractile recovery at time of device implantation, how-
ever, is not associated with 3 years prognosis. Rather, death or rehospi-
talization can be predicted from QRS duration and LV diastolic volume
at baseline. Whether a contractility-guided approach to CRT implemen-
tation will help in better selection of heart failure patients and long-
term prognosis could not be conﬁrmed in this study.
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